TGA Approval

ALPROLIX eftrenonacog alfa (rhu) 1000 IU powder for injection vial and diluent pre-filled syringe (209224)

ARTG ID

209224

ARTG Name

ALPROLIX eftrenonacog alfa (rhu) 1000 IU powder for injection vial and diluent pre-filled syringe

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

May 1, 2014

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01157-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01156-1

Ingredient Name

eftrenonacog alfa

Empowering clinical research with data-driven insights and AI-powered tools.

ALPROLIX eftrenonacog alfa (rhu) 1000 IU powder for injection vial and diluent pre-filled syringe (209224) - TGA 批准文号 | MedPath